Angina (Stable)
60
12
17
25
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.3%
2 terminated out of 60 trials
92.6%
+6.1% vs benchmark
10%
6 trials in Phase 3/4
8%
2 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (60)
Microvascular Dysfunction in Patients With Long-Covid Syndrome and Angina
Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a Community
iCorMicA - Stratified Medicine in Angina
Coronary Sinus Reducer Therapy for Persisting Angina
Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease
Study of Lesion-Specific Invasive Haemodynamic Angina Thresholds
Advanced NanoTherapies Dual-API DCB to Treat De-Novo and ISR Lesions in Patients With Symptomatic Coronary Artery Disease
Artificial Intelligence in ANOCA
Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)
Coronary Sinus Reducer in Coronary Microvascular Disease
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
Effects of Acupuncture on Symptoms of Stable Angina
The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow
Angina After PCI: a Systems Medicine Study
Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) Trial
Quest to Analyze One Thousand Humans Meditating